
Locations:
Vanessa N. Weitzman, M.D.
Board-certified
Obstetrics and Gynecology
Reproductive Endocrinology and Infertility
Vanessa N. Weitzman, M.D., is a board-certified Reproductive Endocrinologist who sees patients at IVF FLORIDA’s Boca Raton and Margate locations. Dr. Weitzman offers comprehensive fertility care with a focus on in vitro fertilization (IVF), fertility preservation, and treatment for diminished ovarian reserve. She partners closely with patients to create personalized care plans that align with their medical and emotional needs.
Dr. Weitzman earned her medical degree from Boston University School of Medicine and completed her OB/GYN residency at St. Barnabas Medical Center in Livingston, N.J. She joined the practice in 2008 after completing her fellowship in Reproductive Endocrinology and Infertility at the University of Connecticut Health Center. As a native South Floridian, she is proud to serve the community where she grew up.
Dr. Weitzman has a clinical interest in oocyte cryopreservation, particularly for patients with breast cancer or those looking to preserve their fertility for the future. Her research in cryopreservation and in vitro maturation has been published in several peer-reviewed journals, and she continues to explore new advances in the field to better support her patients’ goals.
Dr. Weitzman is committed to providing thoughtful, evidence-based care and supporting patients in their family-building journey.
Locations:
Education
Bachelor of Arts: Boston University, Boston, Mass.
Medical degree: Boston University School of Medicine
Residency in Obstetrics and Gynecology: St. Barnabas Medical Center, Livingston, N.J.
Subspecialty training in Reproductive Endocrinology and Infertility: University of Connecticut Healthcare Center, Farmington, Conn.
Memberships and Positions
American College of Obstetrics and Gynecology
American Society of Reproductive Medicine
Honors
International Health Fellowship
2000
Outstanding Service Award
Mae Tao Clinic
2000
Milford and Barbara Nember Fellow
2001
Cervical Cancer Research Grant
2001
Areas of Experience/Interest
As an infertility specialist, Dr. Weitzman has experience in the areas of in vitro fertilization, diminished ovarian reserve, and advanced laparoscopic surgery. She is also interested in the preservation of future fertility and oocyte cryopreservation. She has been involved in research involving factors affecting oocyte cryopreservation and in vitro maturation.
Hospital Affiliations
Northwest Medical Center
American Society of Reproductive Medicine
Kendall Regional Medical Center
Select Publications
Weitzman VN, Engmann L, Diluigi A, Maier DB, Nulsen JC, Benadiva CA. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol (LPG) before gonadotropin stimulation versus standard microdose lupron protocol for patients with a history of poor IVF outcomes. Fertil Steril. Article in Press.
Weitzman VN, DiLuigi AJ, Maier DB, Nulsen JC. Prevention of recurrent adnexal torsion. Fertil Steril. 2008; April 12. [Epub ahead of print]
Diluigi A, Weitzman VN, Pace MC, Siano LJ, Maier D, Mehlmann LM. Meiotic Arrest in Human Oocytes Is Maintained by a Gs Signalling Pathway. Biol Reprod. 2008; April 78(4):667-72.
Weitzman VN, Engmann L, Diluigi A, Maier DB, Nulsen JC, Benadiva CA. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol (LPG) before gonadotropin stimulation versus standard microdose lupron protocol for patients with a history of poor IVF outcomes. Fert Steril 2006;86:S120.
Weitzman VN, Engmann L, Diluigi A, Maier DB, Nulsen JC, Benadiva CA. Evaluation of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol (LPG) before gonadotropin stimulation in patients with a history of multiple failed cycles. Fert Steril 2006;86:S430
Engmann L, Siano L, Weitzman V, Nulsen J, Maier D, Benadiva C. Induction of oocyte maturation with GnRH agonist in high-risk patients undergoing IVF treatment does not adversely affect implantation rate. Fert Steril 2006;86:S429
Lieman H, Aubuchon M, Stein D, Cohen H, Weitzman VN, Isaac B, Tetrokalashvili M, Santoro N. Metformin does not alter insulin action, androgen production, or induce ovulation in obese women with polycystic ovarian syndrome (Abstract). Society for Gynecologic Investigation, March 2004, Houston, TX.
Mack CK, Chen SH, Porudominsky VN, Cekleniak NA, Sable DB, Garrisi MG. Stability of day 3 FSH levels in relation to various transport containers and heat stress (Abstract). American College of Obstetrics & Gynecology, May 2004, Philadelphia, PA.